The global bone growth stimulator market will likely grow at a compound annual growth rate of 8.5 percent through 2025, according to a Research and Markets report.
Here are three observations:
1. The market's value is positioned to hit $3.9 billion by 2025.
2. The increasing patient demand for noninvasive surgery, rising number of bone-related issues and growing number of investment opportunities will spur market growth.
3. Key market players include ITO, Isto Biologics, Harvest Technologies, Ember Therapeutics, DJO Finance, DePuy Synthes, Bioventus, Arthrex, Orthofix, Medtronic, Altis Biologics, Ossatec Benelux, Regen Lab, Stryker and Zimmer Biomet.